PA8790401A1 - Sulfonamidas como moduladores de trpm8 - Google Patents

Sulfonamidas como moduladores de trpm8

Info

Publication number
PA8790401A1
PA8790401A1 PA20088790401A PA8790401A PA8790401A1 PA 8790401 A1 PA8790401 A1 PA 8790401A1 PA 20088790401 A PA20088790401 A PA 20088790401A PA 8790401 A PA8790401 A PA 8790401A PA 8790401 A1 PA8790401 A1 PA 8790401A1
Authority
PA
Panama
Prior art keywords
sulfonamids
trpm8 modulators
compounds
trpm8
modulators
Prior art date
Application number
PA20088790401A
Other languages
English (en)
Inventor
T Branum Shawn
W Colburn Raymond
L Dax Scott
Ludovici Donald
Matthews Jay
J Mcnally James
K Russell Ronald
Qin Ning
C Youells Scott
Liu Yi
C Jetter Michele
A Youngman Mark
M Wells Kenneth
J Macielag Mark
Reany Laura
M Flores Christopher
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39772848&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PA8790401(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PA8790401A1 publication Critical patent/PA8790401A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/36—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/66—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE DAN A CONOCER COMPUESTOS, COMPOSICIONES Y MÉTODOS PARA TRATAR DIVERSAS ENFERMEDADES, SÍNDROMES, AFECCIONES Y TRASTORNOS, INCLUSO DOLOR. ESTOS COMPUESTOS ESTÁN REPRESENTADOS POR LA FÓRMULA I DE LA MANERA SIGUIENTE: DONDE A,B,G,Y,R1,R2,R3, Y R4 SE DEFINEN EN LA PRESENTE MEMORIA DESCRIPTIVA.
PA20088790401A 2007-07-18 2008-07-18 Sulfonamidas como moduladores de trpm8 PA8790401A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95045607P 2007-07-18 2007-07-18

Publications (1)

Publication Number Publication Date
PA8790401A1 true PA8790401A1 (es) 2009-03-31

Family

ID=39772848

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20088790401A PA8790401A1 (es) 2007-07-18 2008-07-18 Sulfonamidas como moduladores de trpm8

Country Status (27)

Country Link
US (3) US8153682B2 (es)
EP (1) EP2183239B1 (es)
JP (1) JP5539868B2 (es)
KR (1) KR101538391B1 (es)
CN (1) CN101801949B (es)
AR (1) AR067602A1 (es)
AU (3) AU2008275927B8 (es)
BR (1) BRPI0815096A2 (es)
CA (1) CA2693159C (es)
CL (1) CL2008002132A1 (es)
CO (1) CO6251375A2 (es)
CR (1) CR11284A (es)
EA (1) EA201070158A1 (es)
EC (1) ECSP109921A (es)
GT (1) GT201000015A (es)
IL (1) IL203295A (es)
JO (1) JO2853B1 (es)
MX (1) MX2010000690A (es)
MY (1) MY153971A (es)
NI (1) NI201000013A (es)
NZ (1) NZ582555A (es)
PA (1) PA8790401A1 (es)
TW (1) TWI446909B (es)
UA (1) UA99624C2 (es)
UY (1) UY31239A1 (es)
WO (1) WO2009012430A1 (es)
ZA (1) ZA201001157B (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8216547B2 (en) 2008-07-18 2012-07-10 Janssen Pharmaceutica Nv Radiolabelled TRP M8 receptor ligands
JP5713911B2 (ja) * 2008-10-27 2015-05-07 アルザ・コーポレーシヨン 長期放出型経口アセトアミノフェン／トラマドール投与形態
CA2747637A1 (en) 2008-12-18 2010-07-15 Janssen Pharmaceutica Nv Sulfamides as trpm8 modulators
JP2012512880A (ja) * 2008-12-18 2012-06-07 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Ｔｒｐｍ８モジュレーターとしてのスルホンアミド
JP5756457B2 (ja) 2009-04-06 2015-07-29 アジオス ファーマシューティカルズ， インコーポレイテッド ピルビン酸キナーゼｍ２調節剤、治療組成物および関連する使用方法
KR20140071518A (ko) * 2009-05-01 2014-06-12 라퀄리아 파마 인코포레이티드 Ｔｒｐｍ8 길항제로서의 설파모일 벤조산 유도체
TW201105681A (en) * 2009-06-10 2011-02-16 Janssen Pharmaceutica Nv Benzimidazole derivatives useful as TRPM8 channel modulators
TW201103941A (en) * 2009-06-10 2011-02-01 Janssen Pharmaceutica Nv Benzimidazole derivatives useful as TRPM8 channel modulators
ES2352398B1 (es) * 2009-06-25 2011-09-29 Institut Univ. De Ciencia I Tecnologia S.A. N-fenetilsulfonamidas-n-sustituidas para la identificacion de actividad biologica y farmacologica.
US20120122920A1 (en) * 2009-06-26 2012-05-17 Josep Castells Boliart Libraries of n-substituted-n-phenylethylsulfonamides for drug discovery
US8785450B2 (en) 2009-06-29 2014-07-22 Agios Pharmaceuticals, Inc. Therapeutic compounds and compositions
WO2011002816A1 (en) 2009-06-29 2011-01-06 Agios Pharmaceuticals, Inc. Therapeutic compositions and related methods of use
US20120122710A1 (en) * 2009-07-01 2012-05-17 Josep Castells Boliart Libraries of n-substituted-n-phenylethylsulfonamides for the identification of biological and pharmacological activity
AU2010313397B2 (en) 2009-10-30 2015-07-02 Janssen Pharmaceutica Nv Phenoxy-substituted pyrimidines as opioid receptor modulators
DE102010002558A1 (de) 2009-11-20 2011-06-01 Symrise Ag Verwendung physiologischer Kühlwirkstoffe und Mittel enthaltend solche Wirkstoffe
JP2013538784A (ja) 2010-10-01 2013-10-17 ラクオリア創薬株式会社 Ｔｒｐｍ８拮抗剤としてのスルファモイル安息香酸ヘテロ二環性誘導体
US8618150B2 (en) 2010-12-09 2013-12-31 Janssen Pharmaceutica, Nv Imidazo[1,2-α]pyridine sulfonamides as TRPM8 modulators
EP2651898B1 (en) 2010-12-17 2015-12-09 Agios Pharmaceuticals, Inc. Novel n-(4-(azetidine-1-carbonyl)phenyl)-(hetero-)arylsulfonamide derivatives as pyruvate kinase m2 (pmk2) modulators
EP2655350B1 (en) * 2010-12-21 2016-03-09 Agios Pharmaceuticals, Inc. Bicyclic pkm2 activators
US8906384B2 (en) * 2010-12-22 2014-12-09 The United States Of America As Represented By The Secretary Of Agriculture Antiviral activity of bovine type III interferon against foot-and-mouth disease virus
TWI549947B (zh) 2010-12-29 2016-09-21 阿吉歐斯製藥公司 治療化合物及組成物
EP2481727A1 (en) 2011-01-28 2012-08-01 Dompe S.p.A. TRPM8 receptor antagonists
WO2012120398A1 (en) 2011-03-04 2012-09-13 Pfizer Limited Aryl substituted carboxamide derivatives as trpm8 modulators
PT2686302T (pt) * 2011-03-16 2016-11-02 Mitsubishi Tanabe Pharma Corp Compostos de sulfonamida tendo atividade antagonista de trpm8
WO2012151440A1 (en) 2011-05-03 2012-11-08 Agios Pharmaceuticals, Inc. Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia
PL3406251T3 (pl) 2011-05-03 2024-04-29 Agios Pharmaceuticals, Inc. Aktywatory kinazy pirogronianowej do stosowania w terapii
EP2606888A1 (en) 2011-12-19 2013-06-26 Dompe' S.P.A. Trpm8 antagonists
TR201808861T4 (tr) 2011-12-19 2018-07-23 Dompe Farm Spa TRPM8 antagonistleri.
JP5985453B2 (ja) * 2012-09-14 2016-09-06 田辺三菱製薬株式会社 医薬組成物
ES2664977T3 (es) 2012-09-14 2018-04-24 Mitsubishi Tanabe Pharma Corporation Compuesto de sulfonamida
EP2774919A1 (en) * 2013-03-06 2014-09-10 Pharmeste S.R.L. In Liquidazione Novel sulfonamide TRPA1 receptor antagonists
WO2014139144A1 (en) 2013-03-15 2014-09-18 Agios Pharmaceuticals, Inc. Therapeutic compounds and compositions
CA2908378A1 (en) * 2013-05-24 2014-11-27 Nestec S.A. Treatment or prevention of depression using menthol and/or icilin
US8906951B1 (en) 2013-06-24 2014-12-09 Tigercat Pharma, Inc. Use of NK-1 receptor antagonists in pruritus
US9198898B2 (en) 2013-06-24 2015-12-01 Tigercat Pharma, Inc. Use of NK-1 receptor antagonists in pruritus
JP6415560B2 (ja) * 2013-08-23 2018-10-31 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ 末端ヘテロアリールシアノビニレン基を有する化合物および前記化合物の有機太陽電池における使用
HUE043586T2 (hu) 2014-06-23 2019-08-28 Dompe Farm Spa 2-aril-4-hidroxi-1,3-tiazol származékok, melyek jól használhatók TRPM8 inhibitorként neuralgia, fájdalom, COPD és asztma kezelésében
WO2016201227A1 (en) 2015-06-11 2016-12-15 Agios Pharmaceuticals, Inc. Methods of using pyruvate kinase activators
RU2687245C1 (ru) 2015-06-23 2019-05-08 Киссеи Фармасьютикал Ко., Лтд. Производное пиразола или его фармацевтически приемлемая соль
EP3359149A4 (en) 2015-10-06 2019-06-12 Ora, Inc. ANTAGONISTS OF THE TRANSITION RECEPTOR POTENTIAL CENTURY CHANNEL UNTERFAMILY M MEMBER 8 (TRPM8) AND METHOD OF USE
EP3184524A1 (en) * 2015-12-21 2017-06-28 Dompé farmaceutici S.p.A. 4-hydroxy-2-phenyl-1,3-thiazol-5-yl methanone derivatives as trpm8 antagonists
ES2855032T3 (es) * 2016-11-02 2021-09-23 Janssen Pharmaceutica Nv Compuestos de [1,2,4]triazolo[1,5-a]pirimidina como inhibidores de PDE2
MX2020002347A (es) 2017-08-31 2020-10-28 Basf Se Uso de principios activos refrescantes fisiologicos y agentes que contienen dichos principios activos.
CN118108716A (zh) * 2019-04-30 2024-05-31 四川科伦博泰生物医药股份有限公司 苯并噻吩类化合物及其制备方法和用途
TW202216676A (zh) * 2020-07-06 2022-05-01 美商塔朵根公司 用於心理疾病或心理強化的有益苯并噻吩組合物
RU2756587C9 (ru) * 2021-02-12 2021-10-12 Акционерное общество "Отисифарм" Производные 2-ацетамидо-6-гидрокси-бензотиофена и их фармацевтически приемлемые соли, обладающие противовирусной активностью
GB202117129D0 (en) * 2021-11-26 2022-01-12 Epidarex Exeed Ltd Compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9725141D0 (en) * 1997-11-27 1998-01-28 Pharmacia & Upjohn Spa Benzenesulfonamide compounds
DE10215321A1 (de) 2002-04-02 2003-10-23 Metagen Pharmaceuticals Gmbh Trp-p8 Splice Varianten und regulatorische RNA
WO2006040136A1 (en) * 2004-10-13 2006-04-20 Bayer Healthcare Ag Substituted 4-benzyloxy-phenylmethylamide derivatives as cold menthol receptor-1 (cmr-1) antagonists for the treatment of urological disorder
WO2006040103A1 (en) 2004-10-13 2006-04-20 Bayer Healthcare Ag Use of cold menthol receptor modulators for the treatment of respiratory disorders
EP1911753A1 (en) 2005-07-29 2008-04-16 Takeda Pharmaceutical Company Limited Spiro-cyclic compound
WO2007017093A1 (en) 2005-08-04 2007-02-15 Bayer Healthcare Ag Substituted 2-benzyloxy-benzoic acid amide derivatives
WO2007017094A1 (en) 2005-08-04 2007-02-15 Bayer Healthcare Ag Substituted benzyloxy-phenylmethylcarbamate derivatives
WO2007017092A1 (en) * 2005-08-04 2007-02-15 Bayer Healthcare Ag Substituted 4-benzyloxy-benzoic acid amide derivatives
EP2029614B1 (en) * 2006-05-10 2013-01-23 Janssen Pharmaceutica, N.V. Cold menthol receptor-1 antagonists

Also Published As

Publication number Publication date
MX2010000690A (es) 2010-06-25
NZ582555A (en) 2012-06-29
CN101801949B (zh) 2014-09-24
CA2693159C (en) 2016-05-24
EP2183239A1 (en) 2010-05-12
CA2693159A1 (en) 2009-01-22
EA201070158A1 (ru) 2010-08-30
AU2016204436A1 (en) 2016-07-21
EP2183239B1 (en) 2012-08-22
US8809327B2 (en) 2014-08-19
US20120190674A1 (en) 2012-07-26
NI201000013A (es) 2010-07-22
US9434711B2 (en) 2016-09-06
UA99624C2 (uk) 2012-09-10
TW200918045A (en) 2009-05-01
ECSP109921A (es) 2010-02-26
AU2008275927B8 (en) 2014-08-14
AR067602A1 (es) 2009-10-14
CL2008002132A1 (es) 2009-03-06
ZA201001157B (en) 2011-04-28
JP2010533734A (ja) 2010-10-28
AU2014203797A1 (en) 2014-07-31
KR101538391B1 (ko) 2015-07-21
IL203295A (en) 2015-09-24
WO2009012430A1 (en) 2009-01-22
JO2853B1 (en) 2015-03-15
AU2008275927A1 (en) 2009-01-22
US20090264474A1 (en) 2009-10-22
US20140315899A1 (en) 2014-10-23
AU2008275927B2 (en) 2014-08-07
KR20100049598A (ko) 2010-05-12
MY153971A (en) 2015-04-30
CO6251375A2 (es) 2011-02-21
GT201000015A (es) 2012-03-12
CR11284A (es) 2010-08-18
JP5539868B2 (ja) 2014-07-02
BRPI0815096A2 (pt) 2015-07-14
TWI446909B (zh) 2014-08-01
US8153682B2 (en) 2012-04-10
UY31239A1 (es) 2009-03-31
CN101801949A (zh) 2010-08-11

Similar Documents

Publication Publication Date Title
PA8790401A1 (es) Sulfonamidas como moduladores de trpm8
CR20130308A (es) Compuestos y su uso como inhibidores de bace
SV2011003855A (es) Heteroarilos sustituidos
ECSP10010582A (es) Derivados de aminodihidrotiazina como inhibidores de bace para el tratamiento de la enfermedad de alzheimer
EA201000642A1 (ru) 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы
EA201001329A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
BRPI0916286B8 (pt) amidofenóxi-indazóis úteis como inibidores de c-met, seus usos, e composição farmacêutica
EA201290121A1 (ru) Конденсированные гетероциклические соединения в качестве модуляторов ионных каналов
EA201391532A1 (ru) Конденсированные гетероциклические соединения в качестве модуляторов ионных каналов
BR112014026176A2 (pt) dipiridilaminas substituídas e usos das mesmas
CO6450612A2 (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750
MX2009010413A (es) 3-imidazolil-indoles para el tratamiento de enfermedades proliferativas.
EA201001332A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
BR112012010253A8 (pt) compostos de pirimidina como moduladores do receptor delta opioide
MX2019001093A (es) Profarmacos de metilfenidato, procesos de elaboracion y uso de los mismos.
PA8855001A1 (es) Monocarbamas
EA201500403A1 (ru) Соединения, активирующие теломеразу, и способы их применения
EA201001330A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
HN2011001606A (es) Antagonistas de 4-azetidinil -1-heteroaril -ciclohexanol de ccr2
BRPI0820668A2 (pt) Derivados de oxindol substituídos por 5-halogênio e seu uso para tratar doenças dependentes de vasopressina
CR10557A (es) Bencilaminas, un proceso para la produccion y su uso como agentes antiinflamatorios
IN2012DN03846A (es)
ECSP088826A (es) Compuestos heterocíclicos apropiados para tratar trastornos que responden a la modulación del receptor de serotonina 5ht6
EA200970662A1 (ru) Трициклические соединения и их применение в качестве модуляторов глюкокортикоидного рецептора
UY30673A1 (es) Derivados 6, 7 y 8 sustituidos del acido (3r)-5-oxo-2,3-dihidro-5h-tiazolo[3,2a]piridin-3-carboxilico, composiciones farmacéuticas conteniéndolos y aplicaciones.